Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population
Clinical trial NCT06049940 · COMPLETED
Trial details
- NCT number
- NCT06049940
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-10-26
- Enrollment
- 1260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.